DRUG TREATMENT OF CYSTIC FIBROSIS PATIENTS IN RUSSIAN FEDERATION ACCORDING TO THE NATIONAL REGISTER, 2014
https://doi.org/10.18093/0869-0189-2016-26-5-539-555
Abstract
The aim of this study was to analyze drug therapy of patients with cystic fibrosis (CF) in Russia. Methods. Findings of the Russian National Register of CF patients, 2014, were used in this study. The 2014 Register included data for 2,131 patients (2,092 alive and 39 died) from 74 regions of Russia. The median age was 10.2 (15.2) years, 29.2% of patients were aged 18 years and older. We analyzed administration of bronchodilators, inhaled corticosteroids (ICS), systemic steroids, dornase alfa, hypertonic saline solution, macrolides, systemic and inhaled antibiotics, pancreatic enzymes, ursodeoxycholic acid, and fat-soluble vitamins. Results. Drug administration rates were as follows: bronchodilators, 65.9%; ICS, 21.7%; systemic steroids, 5.5%; macrolides, 32.4%; dornase-alfa, 92.8%; hypertonic saline solution, 45.9%; intravenous antibiotics, 62.3%; oral antibiotics, 73.3%; inhaled antibiotics, 41.3%; pancreatic enzymes, 93.3%; ursodeoxycholic acid, 91.4%; and fat-soluble vitamins, 88.3%. Conclusion. Compared to treatment of CF patients in the Western Europe, there is higher rate of administration of pancreatic enzymes, ursodeoxycholic acid, dornase alfa, hypertonic saline solution and intravenous antibiotics in Russia. Compared to treatment strategy in USA, there is higher rate of administration of pancreatic enzymes and lower rate of administration of bronchodilators, hypertonic saline solution and inhaled antibiotics in Russia.
About the Authors
S. A. KrasovskiyRussian Federation
PhD, Senior Researcher at Laboratory of Cystic Fibrosis, Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; pneumologist at the 2nd Pulmonology Department of D.D.Pletnev City Clinical Hospital, Moscow Healthcare Department; Senior Researcher at Research and Clinical Division of Cystic Fibrosis, Federal Medical Genetic Academic Center, Russian Academy of Science
E. L. Amelina
Russian Federation
PhD, Head of Laboratory of Cystic Fibrosis
E. I. Kondrat'eva
Russian Federation
MD, Professor, Principal Researcher at Research and Clinical Division of Cystic Fibrosis
A. Yu. Voronkova
Russian Federation
PhD, Senior Researcher at Research and Clinical Division of Cystic Fibrosis
A. V. Chernyak
Russian Federation
PhD, Head of Laboratory of Functional and Ultra-sound Investigations
Yu. V. Gorinova
Russian Federation
PhD, Senior Researcher at Division of Pulmonology and Allergy
M. V. Usacheva
Russian Federation
Researcher at Laboratory of Cystic Fibrosis
N. P. Revel'-Muroz
Russian Federation
PhD, Head of Department of Pulmonology
N. I. Romanenko
Russian Federation
PhD, Head of Pediatric Department
M. G. Rybalkina
Russian Federation
PhD, Assistant Lecturer at Department of Hospital Pediatrics
T. I. Safonova
Russian Federation
Head of Pulmonology Department
N. A. Satsuk
Russian Federation
Head of Pulmonology Department
D. F. Sergienko
Russian Federation
MD, Professor at Department of General Pediatrics
V. N. Seroklinov
Russian Federation
PhD, Associate Professor at Department of Pediatrics, Faculty of Postgraduate Physician Training
T. V. Simanova
Russian Federation
PhD, Head of Pulmonology Department
O. I. Simonova
MD, Head of Department of Pulmonology and Allergology
M. A. Skachkova
MD, Professor, Head of Department of Hospital Pediatrics
V. V. Smirnova
PhD, Head of Pulmonology Department
I. I. Smirnova
Competing Interests: Pediatrician
O. I. Starodubtseva
PhD, Head of Pulmonology Department
T. V. Stashkevich
Head of Pulmonology Department
T. A. Stepanenko
PhD, Head of Pulmonology Department
V. V. Chikunov
PhD, Assistant Lecturer at Department of Pediatrics
L. A. Shabalova
PhD, Senior Researcher at Research and Clinical Division of Cystic Fibrosis
O. I. Golubtsova
PhD, Head of Division of Pulmonology and Allergy
V. V. Shadrina
PhD, Assistant Lecturer at Department of Hospital Pediatrics
O. G. Zonenko
Assistant Lecturer
A. A. Shevlyakova
Pneumologist
V. D. Sherman
PhD, Senior Researcher at Research and Clinical Division of Cystic Fibrosis
N. A. Karchevskaya
Researcher at Laboratory of Non-invasive Diagnostics
Zh. K. Naumenko
PhD, Senior Researcher at Laboratory of Functional and Ultra-sound Investigations
I. N. Butyugina
Pneumologist at the 2nd Pulmonology Department
O. Yu. Gracheva
Head of the 2nd Pulmonology Department
M. S. Kevorkova
PhD student
V. B. Yakovleva
Pneumologist at Pulmonology Department
N. Yu. Kashirskaya
MD, Professor, Principal Researcher at Laboratory of Genetic Epidemiology
Review
For citations:
Krasovskiy S.A., Amelina E.L., Kondrat'eva E.I., Voronkova A.Yu., Chernyak A.V., Gorinova Yu.V., Usacheva M.V., Revel'-Muroz N.P., Romanenko N.I., Rybalkina M.G., Safonova T.I., Satsuk N.A., Sergienko D.F., Seroklinov V.N., Simanova T.V., Simonova O.I., Skachkova M.A., Smirnova V.V., Smirnova I.I., Starodubtseva O.I., Stashkevich T.V., Stepanenko T.A., Chikunov V.V., Shabalova L.A., Golubtsova O.I., Shadrina V.V., Zonenko O.G., Shevlyakova A.A., Sherman V.D., Karchevskaya N.A., Naumenko Zh.K., Butyugina I.N., Gracheva O.Yu., Kevorkova M.S., Yakovleva V.B., Kashirskaya N.Yu. DRUG TREATMENT OF CYSTIC FIBROSIS PATIENTS IN RUSSIAN FEDERATION ACCORDING TO THE NATIONAL REGISTER, 2014. PULMONOLOGIYA. 2016;26(5):539-555. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-5-539-555